文献速递头颈部肿瘤放疗

吸烟对鼻咽癌生存的影响:23325例患者的队列研究

Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016.
PubMed 文献 · Radiother Oncol · 2021-06-25

该队列纳入1990至2016年23325例鼻咽癌患者,比较不同吸烟行为患者的生存结局。全队列5年总生存率在 former、current 和 never smokers 中分别为76.4%、68.9%和79.8%。在IMRT时代,former或current smoker是DMFS的独立危险因素,OS和LRFS差异仅见于current smoker与never smoker之间。

要点

  • 全队列5年OS率:former smoker 76.4%,current smoker 68.9%,never smoker 79.8%。
  • IMRT队列中former和current smoker的5年DMFS低于never smoker(P=0.004和P<0.001)。
  • IMRT队列多因素分析中current smoker死亡和复发风险更高,former和current smoker转移风险更高。

核心结论

  • 在IMRT时代,former smoker或current smoker是鼻咽癌DMFS的独立危险因素。
  • OS和LRFS的显著差异仅存在于current smoker与never smoker之间。

研究设计与样本

  • 回顾性队列研究,纳入1990至2016年23325例鼻咽癌患者。
  • 主要终点为总生存(OS),采用log-rank检验和Cox比例风险回归模型评估生存结局。

主要发现

  • 全队列5年OS率在former、current和never smokers中分别为76.4%、68.9%和79.8%。
  • IMRT队列中OS率呈现相同趋势。
  • 与never smoker相比,former smoker(P=0.004)和current smoker(P<0.001)的5年DMFS更低。
  • IMRT队列多因素分析中,current smoker死亡风险(P=0.003)和复发风险(P=0.027)更高。
  • former smoker(P=0.031)和current smoker(P=0.019)的转移风险高于never smoker。

关键数值与推荐

  • 全队列5年OS率:former smoker 76.4%,current smoker 68.9%,never smoker 79.8%。
  • IMRT队列中former smoker与never smoker的5年DMFS比较P=0.004。
  • IMRT队列中current smoker与never smoker的5年DMFS比较P<0.001。
  • IMRT队列多因素分析中current smoker死亡风险P=0.003,复发风险P=0.027。
  • IMRT队列多因素分析中former smoker转移风险P=0.031,current smoker转移风险P=0.019。

临床怎么用

  • 对鼻咽癌患者应采集吸烟状态,former或current smoker在IMRT时代需关注DMFS风险。
  • current smoker的OS和LRFS结局更差,提示戒烟干预可能有助于改善生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to compare the survival outcomes of patients with nasopharyngeal carcinoma (NPC) who had different smoking behaviors and were treated with two- or three-dimensional radiotherapy (2D/3DRT) or intensity-modulated radiotherapy (IMRT) with a long-term follow up. METHODS: From 1990 to 2016, 23,325 patients with NPC were included. The primary endpoint of this study was overall survival (OS). The log-rank test and Cox proportional hazards regression model were used to assess the patients' survival outcomes. RESULTS: The 5-year OS rates in the entire cohort were 76.4%, 68.9%, and 79.8% in the former, current, and never smokers, respectively. In the IMRT cohort, the OS rates showed the same trend. Compared with the never smokers, the 5-year distant metastasis-free survival (DMFS) was lower in the former (P = 0.004) and current smokers (P < 0.001). In the multivariate analysis of the IMRT cohort, the risk of death (P = 0.003) and recurrence (P = 0.027) was higher in the current smokers, while the risk of metastasis was higher in the former and current smokers (P = 0.031 and P = 0.019, respectively) than the never smokers. A total of 53.9% of the effect of smoking status on OS was through sex, age, and Epstein-Barr virus DNA, which were significant mediators. CONCLUSION: In the IMRT era, being a former smoker or current smoker was an independent risk factor for DMFS. The difference in OS and locoregional relapse-free survival was significant only between the current smokers and never smokers.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Sun XS, Xie SY, Luo DH, et al. Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016. Radiother Oncol. 2021. PMID: 34182012. doi:10.1016/j.radonc.2021.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。